Phase I trial of gemcitabine and capecitabine (xeloda) in patients with advanced pancreatic carcinoma

Trial Profile

Phase I trial of gemcitabine and capecitabine (xeloda) in patients with advanced pancreatic carcinoma

Completed
Phase of Trial: Phase I

Latest Information Update: 09 Mar 2010

At a glance

  • Drugs Capecitabine; Gemcitabine
  • Indications Pancreatic cancer
  • Focus Adverse reactions
  • Most Recent Events

    • 09 Mar 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 24 Jun 2008 Status changed from recruiting to in progress according to ClinicalTrials.gov.
    • 23 Jun 2008 Primary endpoints identified, as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top